Journal of Medicinal Chemistry · 2018 · 56 citations · 23 references
Life SciencesBiochemistryMolecular BiologyDrug DesignDrug DiscoveryEnzymologyCovalent Inhibitor DesignEnzyme DiscoveryEnzyme InhibitionLigand BindingLigand-based DesignNadph MetabolismBiochemical CharacterizationCovalent Modification Of EnzymesCrystallographic CharacterizationEnzyme Inhibitor DiscoveryReversible Covalent ChemistryReversible Covalent InhibitionReversible Covalent InhibitorsSmall Molecule Drug Design
IDH1 plays a critical role in a number of metabolic processes and serves as a key source of cytosolic NADPH under conditions of cellular stress. However, few inhibitors of wild-type IDH1 have been reported. Here we present the discovery and biochemical characterization of two novel inhibitors of wild-type IDH1. In addition, we present the first ligand-bound crystallographic characterization of these novel small molecule IDH1 binding pockets. Importantly, the NADPH competitive α,β-unsaturated enone 1 makes a unique covalent linkage through active site H315. As few small molecules have been shown to covalently react with histidine residues, these data support the potential utility of an underutilized strategy for reversible covalent small molecule design.
23
<i>IDH1</i>and<i>IDH2</i>Mutations in Gliomas
Hai Yan, D. Williams Parsons, Genglin Jin et al. · New England Journal of Medicine · 2009 · 5.9K citations · Full text
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
D. Williams Parsons, Siân Jones, Xiaosong Zhang et al. · Science · 2008 · 5.8K citations · Full text
The National Center for Biotechnology Information
D. A. Benson, Mark S. Boguski, David J. Lipman et al. · Genomics · 1990 · 5.2K citations · Full text
Comprehensive molecular characterization of clear cell renal cell carcinoma
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis, Li Ding, David J. Dooling et al. · New England Journal of Medicine · 2009 · 2.2K citations · Full text